A citation-based method for searching scientific literature

Ryota Shinohara, George K Aghajanian, Chadi G Abdallah. Biol Psychiatry 2021
Times Cited: 5







List of co-cited articles
25 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants.
Ronald S Duman, George K Aghajanian, Gerard Sanacora, John H Krystal. Nat Med 2016
601
60

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Carlos A Zarate, Jaskaran B Singh, Paul J Carlson, Nancy E Brutsche, Rezvan Ameli, David A Luckenbaugh, Dennis S Charney, Husseini K Manji. Arch Gen Psychiatry 2006
60

NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses.
Anita E Autry, Megumi Adachi, Elena Nosyreva, Elisa S Na, Maarten F Los, Peng-fei Cheng, Ege T Kavalali, Lisa M Monteggia. Nature 2011
60

Antidepressant effects of ketamine in depressed patients.
R M Berman, A Cappiello, A Anand, D A Oren, G R Heninger, D S Charney, J H Krystal. Biol Psychiatry 2000
60

mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists.
Nanxin Li, Boyoung Lee, Rong-Jian Liu, Mounira Banasr, Jason M Dwyer, Masaaki Iwata, Xiao-Yuan Li, George Aghajanian, Ronald S Duman. Science 2010
60

Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression.
James W Murrough, Andrew M Perez, Sarah Pillemer, Jessica Stern, Michael K Parides, Marije aan het Rot, Katherine A Collins, Sanjay J Mathew, Dennis S Charney, Dan V Iosifescu. Biol Psychiatry 2013
428
60

Antidepressant Potential of (R)-Ketamine in Rodent Models: Comparison with (S)-Ketamine.
Kenichi Fukumoto, Hidetoh Toki, Michihiko Iijima, Takashi Hashihayata, Jun-Ichi Yamaguchi, Kenji Hashimoto, Shigeyuki Chaki. J Pharmacol Exp Ther 2017
114
40

A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression.
Nancy Diazgranados, Lobna Ibrahim, Nancy E Brutsche, Andrew Newberg, Phillip Kronstein, Sami Khalife, William A Kammerer, Zenaide Quezado, David A Luckenbaugh, Giacomo Salvadore,[...]. Arch Gen Psychiatry 2010
622
40



Ketamine Treatment and Global Brain Connectivity in Major Depression.
Chadi G Abdallah, Lynnette A Averill, Katherine A Collins, Paul Geha, Jaclyn Schwartz, Christopher Averill, Kaitlin E DeWilde, Edmund Wong, Alan Anticevic, Cheuk Y Tang,[...]. Neuropsychopharmacology 2017
129
40

R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects.
C Yang, Y Shirayama, J-c Zhang, Q Ren, W Yao, M Ma, C Dong, K Hashimoto. Transl Psychiatry 2015
283
40

Single, Repeated, and Maintenance Ketamine Infusions for Treatment-Resistant Depression: A Randomized Controlled Trial.
Jennifer L Phillips, Sandhaya Norris, Jeanne Talbot, Meagan Birmingham, Taylor Hatchard, Abigail Ortiz, Olabisi Owoeye, Lisa A Batten, Pierre Blier. Am J Psychiatry 2019
115
40

Rapid-acting glutamatergic antidepressants: the path to ketamine and beyond.
John H Krystal, Gerard Sanacora, Ronald S Duman. Biol Psychiatry 2013
259
40

Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study.
Vanina Popova, Ella J Daly, Madhukar Trivedi, Kimberly Cooper, Rosanne Lane, Pilar Lim, Christine Mazzucco, David Hough, Michael E Thase, Richard C Shelton,[...]. Am J Psychiatry 2019
164
40

Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD).
Maurizio Fava, Marlene P Freeman, Martina Flynn, Heidi Judge, Bettina B Hoeppner, Cristina Cusin, Dawn F Ionescu, Sanjay J Mathew, Lee C Chang, Dan V Iosifescu,[...]. Mol Psychiatry 2020
101
40

Decreased expression of synapse-related genes and loss of synapses in major depressive disorder.
Hyo Jung Kang, Bhavya Voleti, Tibor Hajszan, Grazyna Rajkowska, Craig A Stockmeier, Pawel Licznerski, Ashley Lepack, Mahesh S Majik, Lak Shin Jeong, Mounira Banasr,[...]. Nat Med 2012
396
40

Repeated oral ketamine for out-patient treatment of resistant depression: randomised, double-blind, placebo-controlled, proof-of-concept study.
Yoav Domany, Maya Bleich-Cohen, Ricardo Tarrasch, Roi Meidan, Olga Litvak-Lazar, Nadav Stoppleman, Shaul Schreiber, Miki Bloch, Talma Hendler, Haggai Sharon. Br J Psychiatry 2019
34
40

Intravenous arketamine for treatment-resistant depression: open-label pilot study.
Gustavo C Leal, Igor D Bandeira, Fernanda S Correia-Melo, Manuela Telles, Rodrigo P Mello, Flavia Vieira, Cassio S Lima, Ana Paula Jesus-Nunes, Lívia N F Guerreiro-Costa, Roberta F Marback,[...]. Eur Arch Psychiatry Clin Neurosci 2021
61
40

Synaptic dysfunction in depression: potential therapeutic targets.
Ronald S Duman, George K Aghajanian. Science 2012
711
40

Ketamine: A Paradigm Shift for Depression Research and Treatment.
John H Krystal, Chadi G Abdallah, Gerard Sanacora, Dennis S Charney, Ronald S Duman. Neuron 2019
108
40

New approaches to antidepressant drug discovery: beyond monoamines.
Olivier Berton, Eric J Nestler. Nat Rev Neurosci 2006
40

Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression.
Marije aan het Rot, Katherine A Collins, James W Murrough, Andrew M Perez, David L Reich, Dennis S Charney, Sanjay J Mathew. Biol Psychiatry 2010
418
40

NMDAR inhibition-independent antidepressant actions of ketamine metabolites.
Panos Zanos, Ruin Moaddel, Patrick J Morris, Polymnia Georgiou, Jonathan Fischell, Greg I Elmer, Manickavasagom Alkondon, Peixiong Yuan, Heather J Pribut, Nagendra S Singh,[...]. Nature 2016
744
40

Antidepressant drugs act by directly binding to TRKB neurotrophin receptors.
Plinio C Casarotto, Mykhailo Girych, Senem M Fred, Vera Kovaleva, Rafael Moliner, Giray Enkavi, Caroline Biojone, Cecilia Cannarozzo, Madhusmita Pryiadrashini Sahu, Katja Kaurinkoski,[...]. Cell 2021
60
40

Glutamate imaging (GluCEST) lateralizes epileptic foci in nonlesional temporal lobe epilepsy.
Kathryn Adamiak Davis, Ravi Prakash Reddy Nanga, Sandhitsu Das, Stephanie H Chen, Peter N Hadar, John R Pollard, Timothy H Lucas, Russell T Shinohara, Brian Litt, Hari Hariharan,[...]. Sci Transl Med 2015
98
20

Ketamine modulates hippocampal neurochemistry and functional connectivity: a combined magnetic resonance spectroscopy and resting-state fMRI study in healthy volunteers.
N V Kraguljac, M A Frölich, S Tran, D M White, N Nichols, A Barton-McArdle, M A Reid, M S Bolding, A C Lahti. Mol Psychiatry 2017
61
20

Hippocampal glutamate is increased and associated with risky drinking in young adults with major depression.
Daniel F Hermens, Kate M Chitty, Rico Sc Lee, Ashleigh Tickell, Paul S Haber, Sharon L Naismith, Ian B Hickie, Jim Lagopoulos. J Affect Disord 2015
21
20

Selecting the reference image for registration of CEST series.
Yi Zhang, Hye-Young Heo, Dong-Hoon Lee, Xuna Zhao, Shanshan Jiang, Kai Zhang, Haiyun Li, Jinyuan Zhou. J Magn Reson Imaging 2016
33
20

Diminished reward responsiveness is associated with lower reward network GluCEST: an ultra-high field glutamate imaging study.
Valerie J Sydnor, Bart Larsen, Christian Kohler, Andrew J D Crow, Sage L Rush, Monica E Calkins, Ruben C Gur, Raquel E Gur, Kosha Ruparel, Joseph W Kable,[...]. Mol Psychiatry 2021
2
50


In vivo imaging of brain glutamate defects in a knock-in mouse model of Huntington's disease.
Jérémy Pépin, Laetitia Francelle, Maria-Angeles Carrillo-de Sauvage, Lucie de Longprez, Pauline Gipchtein, Karine Cambon, Julien Valette, Emmanuel Brouillet, Julien Flament. Neuroimage 2016
41
20


MRSI vs CEST MRI to understand tomato metabolism in ripening fruit: is there a better contrast?
Guilhem Pagés, Catherine Deborde, Martine Lemaire-Chamley, Annick Moing, Jean-Marie Bonny. Anal Bioanal Chem 2021
1
100


A Resting-State Functional MR Imaging and Spectroscopy Study of the Dorsal Hippocampus in the Chronic Unpredictable Stress Rat Model.
Ricardo Magalhães, Ashley Novais, David A Barrière, Paulo Marques, Fernanda Marques, João C Sousa, João J Cerqueira, Arnaud Cachia, Therese M Jay, Michel Bottlaender,[...]. J Neurosci 2019
12
20

Altered neuronal spontaneous activity correlates with glutamate concentration in medial prefrontal cortex of major depressed females: An fMRI-MRS study.
Xiaoliu Zhang, Yingying Tang, Mirjana Maletic-Savatic, Jianhua Sheng, Xuanhong Zhang, Yajing Zhu, Tianhong Zhang, Junjie Wang, Shanbao Tong, Jijun Wang,[...]. J Affect Disord 2016
26
20



GABAergic mechanisms of hippocampal hyperactivity in schizophrenia.
Stephan Heckers, Christine Konradi. Schizophr Res 2015
143
20



The neurobiology of depression, ketamine and rapid-acting antidepressants: Is it glutamate inhibition or activation?
Chadi G Abdallah, Gerard Sanacora, Ronald S Duman, John H Krystal. Pharmacol Ther 2018
83
20



Glutamate imaging (GluCEST) reveals lower brain GluCEST contrast in patients on the psychosis spectrum.
D R Roalf, R P R Nanga, P E Rupert, H Hariharan, M Quarmley, M E Calkins, E Dress, K Prabhakaran, M A Elliott, P J Moberg,[...]. Mol Psychiatry 2017
46
20


Analysis of chemical exchange saturation transfer contributions from brain metabolites to the Z-spectra at various field strengths and pH.
Vitaliy Khlebnikov, Wybe J M van der Kemp, Hans Hoogduin, Dennis W J Klomp, Jeanine J Prompers. Sci Rep 2019
16
20

Effect of Ketamine on Limbic GABA and Glutamate: A Human In Vivo Multivoxel Magnetic Resonance Spectroscopy Study.
Leo R Silberbauer, Benjamin Spurny, Patricia Handschuh, Manfred Klöbl, Petr Bednarik, Birgit Reiter, Vera Ritter, Patricia Trost, Melisande E Konadu, Marita Windpassinger,[...]. Front Psychiatry 2020
4
25



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.